Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.6827.6932.55-13.1679.82

What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?

The latest Core EBITDA Growth ratio of MARKSANS PHARMA is 17.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.68
Mar202427.69
Mar202332.55
Mar2022-13.16
Mar202179.82

How is Core EBITDA Growth of MARKSANS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 17.68
-36.15
Mar2024 27.69
-14.93
Mar2023 32.55
Positive
Mar2022 -13.16
Negative
Mar2021 79.82 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,232.4 Cr -2.7% 5.3% -31.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.7%

5.3%

-31.2%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses